Citigroup’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-754,909
| Closed | -$36.2M | – | 5310 |
|
|
2020
Q1 | $36.2M | Sell |
754,909
-991,587
| -57% | -$47.6M | 0.03% | 277 |
|
|
2019
Q4 | $82M | Buy |
1,746,496
+1,694,524
| +3,260% | +$79.5M | 0.06% | 179 |
|
|
2019
Q3 | $1.23M | Sell |
51,972
-2,997
| -5% | -$70.9K | ﹤0.01% | 1970 |
|
|
2019
Q2 | $1.65M | Buy |
54,969
+51,260
| +1,382% | +$1.54M | ﹤0.01% | 1783 |
|
|
2019
Q1 | $84K | Buy |
3,709
+582
| +19% | +$13.2K | ﹤0.01% | 3700 |
|
|
2018
Q4 | $57K | Buy |
3,127
+45
| +1% | +$820 | ﹤0.01% | 3833 |
|
|
2018
Q3 | $56K | Buy |
+3,082
| New | +$56K | ﹤0.01% | 4003 |
|
|
2018
Q2 | – | Sell |
-2,225
| Closed | -$11K | – | 5159 |
|
|
2018
Q1 | $11K | Buy |
2,225
+2,037
| +1,084% | +$10.1K | ﹤0.01% | 4465 |
|
|
2017
Q4 | $2K | Buy |
188
+186
| +9,300% | +$1.98K | ﹤0.01% | 4848 |
|
|
2017
Q3 | $0 | Sell |
2
-124
| -98% | – | ﹤0.01% | 4970 |
|
|
2017
Q2 | $2K | Buy |
126
+21
| +20% | +$333 | ﹤0.01% | 4625 |
|
|
2017
Q1 | $2K | Sell |
105
-8,158
| -99% | -$155K | ﹤0.01% | 4671 |
|
|
2016
Q4 | $125K | Buy |
+8,263
| New | +$125K | ﹤0.01% | 3822 |
|